Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001510281-24-000535
Filing Date
2024-10-17
Accepted
2024-10-17 10:54:27
Documents
1
Period of Report
2024-10-15

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 5729
  Complete submission text file 0001510281-24-000535.txt   7790
Mailing Address 405 LEXINGTON AVENUE 58TH FLOOR NEW YORK NY 10174
Business Address 405 LEXINGTON AVENUE 58TH FLOOR NEW YORK NY 10174 212-542-4635
Saba Capital Management, L.P. (Reporting) CIK: 0001510281 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 811-23466 | Film No.: 241376381

Mailing Address 405 LEXINGTON AVENUE 58TH FLOOR NEW YORK NY 10174
Business Address
Weinstein Boaz (Reporting) CIK: 0001608233 (see all company filings)

Type: 4 | Act: 34 | File No.: 811-23466 | Film No.: 241376380

Mailing Address 100 BELLEVUE PARKWAY WILMINGTON DE 19809
Business Address 100 BELLEVUE PARKWAY WILMINGTON DE 19809 800 882 0052
BlackRock Health Sciences Term Trust (Issuer) CIK: 0001785971 (see all company filings)

IRS No.: 000000000 | State of Incorp.: MD | Fiscal Year End: 1231